TauRx Therapeutics Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- TauRx Therapeutics Ltd.'s estimated annual revenue is currently $11.2M per year.
- TauRx Therapeutics Ltd.'s estimated revenue per employee is $140,000
Employee Data
- TauRx Therapeutics Ltd. has 80 Employees.
- TauRx Therapeutics Ltd. grew their employee count by -4% last year.
TauRx Therapeutics Ltd.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Procurement | Reveal Email/Phone |
2 | Head DMPK / Analytical Chemistry | Reveal Email/Phone |
3 | Head Operations (Clinical) | Reveal Email/Phone |
4 | Head Projects | Reveal Email/Phone |
5 | Head IT and Infrastructure | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Commercial Director | Reveal Email/Phone |
8 | Chief Operating Officer and Chief Business Officer | Reveal Email/Phone |
9 | Legal Counsel and Data Protection Officer | Reveal Email/Phone |
10 | Data Vendor Management Officer | Reveal Email/Phone |
TauRx Therapeutics Ltd. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is TauRx Therapeutics Ltd.?
TauRx was established to address one of the world's biggest challenges – beating Alzheimer's and other degenerative brain disorders through a completely new approach. A leader in Alzheimer's research, the company's mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative disorders. TauRx's strong research team, supported through cooperative relationships with multiple academic institutions around the world, has focussed on the tau pathway, believed to be one of the critical causes of neurodegeneration in the brain. The company's novel tau aggregation inhibitors (TAIs) target the formation of tau protein ‘tangles' in the brain and its lead compound LMTX® inhibits aggregation of tau, synuclein, TPD-43 and huntingtin proteins. LMTX® is currently in development for the treatment and prevention of Alzheimer's and bvFTD. TauRx is incorporated in Singapore with primary research and operations in Aberdeen, Scotland.
keywords:N/A
N/A
Total Funding
80
Number of Employees
$11.2M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TauRx Therapeutics Ltd. News
Ltd., H. Lundbeck A/S, AC Immune, TauRx Pharmaceuticals Ltd., Actavis plc., Forest Laboratories, Teva Pharmaceuticals Industries Ltd.,...
... with industry research collaborations, and companies developed from within the department (e.g. TauRx Therapeutics, GyreOx Ltd.).
Pfizer Merck & Co. Inc., Novartis AG, Eisai Co. Ltd., H. Lundbeck A/S, AC Immune, TauRx Pharmaceuticals Ltd., Actavis plc., Forest Laboratories,...
Other Companies in Aberdeen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.8M | 81 | 3% | N/A |
#2 | $14.1M | 81 | 47% | N/A |
#3 | $16.6M | 82 | 41% | N/A |
#4 | $20.3M | 83 | 0% | N/A |
#5 | $3.5M | 85 | 27% | N/A |